欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2114/003
药品名称
Sitagliptin Grindeks
活性成分
Sitagliptin Hydrochloride monohydrate 100.0 mg
剂型
Film-coated tablet
上市许可持有人
Grindeks AS, Latvia
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Greece (EL)
Norway (NO)
Croatia (HR)
United Kingdom (Northern Ireland) (XI)
Belgium (BE)
Sitagliptin Grindeks 100 mg comprimés pelliculés
Poland (PL)
Sitagliptin Grindeks
Malta (MT)
Netherlands (NL)
Latvia (LV)
Luxembourg (LU)
Ireland (IE)
Estonia (EE)
Austria (AT)
Hungary (HU)
Sitagliptin Grindeks 100 mg filmtabletta
Bulgaria (BG)
Spain (ES)
Czech Republic (CZ)
Sitagliptin Grindeks
Portugal (PT)
Romania (RO)
Sitagliptin Grindeks 100 mg, comprimate filmate
Italy (IT)
France (FR)
Lithuania (LT)
Sitagliptin Grindeks 100 mg plėvele dengtos tabletės
Finland (FI)
Denmark (DK)
Germany (DE)
Sitagliptin Grindeks 100 mg Filmtabletten
Slovenia (SI)
Slovak Republic (SK)
许可日期
2021/12/22
最近更新日期
2023/08/23
药物ATC编码
A10BH01 sitagliptin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR Summary
|
PAR Summary
Date of last change:2025/07/04
PubAR
|
New Document
Date of last change:2024/09/06
Final PL
|
Final PL
Final SPC
|
Final SPC
PubAR
|
PAR
市场状态
Positive
©2006-2026
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase